Raiffeisen Bank International AG Acquires New Position in Oscar Health, Inc. $OSCR

Raiffeisen Bank International AG acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 61,881 shares of the company’s stock, valued at approximately $1,171,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Farther Finance Advisors LLC grew its holdings in shares of Oscar Health by 4,420.7% during the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after buying an additional 1,282 shares during the last quarter. Jones Financial Companies Lllp lifted its position in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares in the last quarter. Strs Ohio purchased a new stake in Oscar Health during the 1st quarter valued at $30,000. Atlantic Union Bankshares Corp bought a new stake in shares of Oscar Health in the 2nd quarter worth $33,000. Finally, Tsfg LLC purchased a new position in shares of Oscar Health in the third quarter worth $38,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Price Performance

Shares of Oscar Health stock opened at $13.25 on Monday. The stock has a market cap of $3.94 billion, a P/E ratio of -7.61 and a beta of 1.90. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.96 and a current ratio of 0.96. The stock’s fifty day moving average is $14.95 and its 200 day moving average is $16.71. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The company had revenue of $2.76 billion during the quarter, compared to analysts’ expectations of $3.12 billion. During the same quarter in the previous year, the company earned ($0.62) EPS. The business’s quarterly revenue was up 17.3% compared to the same quarter last year. Sell-side analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently commented on the stock. UBS Group reiterated a “neutral” rating and issued a $15.00 price target on shares of Oscar Health in a research note on Wednesday, February 11th. Wall Street Zen raised Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a report on Thursday, February 12th. Barclays set a $18.00 target price on Oscar Health and gave the stock an “equal weight” rating in a research report on Monday, January 5th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a research report on Thursday, January 22nd. Two research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $16.88.

Insider Activity

In other Oscar Health news, insider Mario Schlosser sold 23,038 shares of Oscar Health stock in a transaction that occurred on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total transaction of $406,620.70. Following the transaction, the insider owned 350,180 shares of the company’s stock, valued at $6,180,677. The trade was a 6.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Adam Mcananey sold 1,852 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $30,724.68. Following the completion of the transaction, the insider owned 179,241 shares of the company’s stock, valued at approximately $2,973,608.19. The trade was a 1.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 197,125 shares of company stock worth $3,265,300 in the last quarter. 25.11% of the stock is currently owned by insiders.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.